Biogen Gains on Low Volume – Zacks Tale of the Tape
Source: http://www.zacks.com/stock/news/21186/Biogen+Gains+on+Low+Volume+-+Zacks+Tale+of+the+TapePosted on Wednesday, June 17th, 2009 | In Market Commentary, Stocks to Watch
Contributed by: Zacks Market Commentaries (http://www.zacks.com/) -
Biogen Idec Inc. (BIIB) swelled almost 3% today on low volume of 1.5 million shares, versus the average of about 2.4 million.
The company earned $1.05 per share in its first quarter, which was 5% better than the average forecast.
In each of the last 4 quarters, this Zacks #2 Rank (”Buy”) company surpassed analysts’ expectations by an average of 6.2%.
“BIIB” Free Stock Analysis: Buy? Sell? Hold?
Zacks Investment Research
Last 5 posts by Zacks Market Commentaries
- CNP & FPL Ink Pipeline Deal - Analyst Blog - November 20th, 2009
- Buffett Borrows for Rail Acquisition - Analyst Blog - November 20th, 2009
- Stone Energy Outdoes Estimates - Analyst Blog - November 20th, 2009
- Smucker's Beats, Raises Guidance - Analyst Blog - November 20th, 2009
- GameStop Meets Expectations - Analyst Blog - November 20th, 2009
 About Zacks Market Commentaries (http://www.zacks.com/)
Zacks Market Commentaries |
No recommendations, either expressed or implied, are being made to buy, sell, hold or short any of the mentioned stocks. No legal, tax or accounting advice is expressed or implied. Always contact your attorney, CPA, or tax advisor before acting on any legal or tax issues. StraightStocks.com is not responsible for the content, products, or services of any of the advertisers on this site. StraightStocks.com receives compensation from advertisers on this blog. Services and products referred to herein are trademarks, registered trademarks, servicemarks, and/or registered servicemarks of their respective trademark or servicemark owners.